These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 8159650)
41. [Clinical and etiologic features of hepatocarcinoma in Sicily]. Carroccio A; Soresi M; Bonfissuto G; Magliarisi C; Anastasi G; Vuturo O; Notarbartolo A; Montalto G Ann Ital Med Int; 1999; 14(4):233-8. PubMed ID: 10638015 [TBL] [Abstract][Full Text] [Related]
42. Tenascin and type IV collagen expression in liver cell dysplasia and in hepatocellular carcinoma. Zhao M; Laissue JA; Zimmermann A Histol Histopathol; 1996 Apr; 11(2):323-33. PubMed ID: 8861754 [TBL] [Abstract][Full Text] [Related]
43. Liver-cell dysplasia and hepatocellular carcinoma. Podda M; Roncalli M; Battezzati PM; Borzio M; Bruno S; Servida E; Coggi G Ital J Gastroenterol; 1992 Jan; 24(1):39-42. PubMed ID: 1315175 [TBL] [Abstract][Full Text] [Related]
44. [Expression of GST-pi and HBV infection in hepatocellular carcinoma]. Shen LJ; Zhang ZJ; Zhang HX; Yang WB; Huang R Ai Zheng; 2002 Jan; 21(1):29-32. PubMed ID: 12500393 [TBL] [Abstract][Full Text] [Related]
45. Clinicopathological characteristics of surgically resected minute hepatocellular carcinomas. Maeda T; Takenaka K; Taguchi K; Kajiyama K; Shirabe K; Shimada M; Tsuneyoshi M; Sugimachi K Hepatogastroenterology; 2000; 47(32):498-503. PubMed ID: 10791221 [TBL] [Abstract][Full Text] [Related]
46. Alpha 1-antitrypsin deficiency and liver cirrhosis in adults. An analysis of 35 Swedish autopsied cases. Eriksson S Acta Med Scand; 1987; 221(5):461-7. PubMed ID: 3496734 [TBL] [Abstract][Full Text] [Related]
47. No association between genetic hemochromatosis and alpha1-antitrypsin deficiency. Fargion S; Bissoli F; Fracanzani AL; Suigo E; Sergi C; Taioli E; Ceriani R; Dimasi V; Piperno A; Sampietro M; Fiorelli G Hepatology; 1996 Nov; 24(5):1161-4. PubMed ID: 8903392 [TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma. El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963 [TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical characterization of 130 cases of primary hepatic carcinomas. Ferrandez-Izquierdo A; Llombart-Bosch A Pathol Res Pract; 1987 Dec; 182(6):783-91. PubMed ID: 2449680 [TBL] [Abstract][Full Text] [Related]
50. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules. Kwon Y; Lee SK; Kim JS; Ro JY; Yu E Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757 [TBL] [Abstract][Full Text] [Related]
51. p53 expression in hepatocellular carcinoma in Greece. Correlation with epidemiological and histopathological data. Skopelitou A; Hadjiyannakis M; Alexopoulou V; Kamina S; Krikoni O; Agnantis NJ Pathol Res Pract; 1996 Nov; 192(11):1100-6. PubMed ID: 9122028 [TBL] [Abstract][Full Text] [Related]
52. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C. Matsuoka S; Nirei K; Tamura A; Nakamura H; Matsumura H; Oshiro S; Arakawa Y; Yamagami H; Tanaka N; Moriyama M Intervirology; 2008; 51(5):352-61. PubMed ID: 19127078 [TBL] [Abstract][Full Text] [Related]
53. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection. Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876 [TBL] [Abstract][Full Text] [Related]
54. Liver cell dysplasia and hepatitis B surface and core antigens in cirrhosis and hepatocellular carcinoma of autopsy cases. Sakurai M Acta Pathol Jpn; 1978 Sep; 28(5):705-19. PubMed ID: 216229 [TBL] [Abstract][Full Text] [Related]
55. [Heterozygous alpha-1-antitrypsin deficiency (PiMZ): risk factor in the development of primary liver carcinoma in non-cirrhotic liver?]. Manekeller S; Sauerbruch T; Fischer HP; Propping P; Hirner A Z Gastroenterol; 2010 Oct; 48(10):1211-4. PubMed ID: 20886426 [TBL] [Abstract][Full Text] [Related]
56. [Primary liver cell carcinoma as complication of alpha 1-antitrypsin deficiency in a 67 year old man]. van den Hazel SJ; Meijer JW; van den Elshout FJ; de Vries RA Ned Tijdschr Geneeskd; 2000 Nov; 144(47):2269-72. PubMed ID: 11109473 [TBL] [Abstract][Full Text] [Related]
57. Alpha-1-antitrypsin deficiency and liver diseases in Nigeria. Olusi SO Trop Geogr Med; 1990 Jan; 42(1):41-6. PubMed ID: 2175465 [TBL] [Abstract][Full Text] [Related]
58. Human hepatocellular carcinoma and putative precancerous disorders: their enzyme histochemical study. Uchida T; Miyata H; Shikata T Arch Pathol Lab Med; 1981 Apr; 105(4):180-6. PubMed ID: 6111303 [TBL] [Abstract][Full Text] [Related]
59. Alterations of p53, Bcl-2, and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinomas in Upper Egypt. Hussein MR Liver Int; 2004 Dec; 24(6):552-60. PubMed ID: 15566504 [TBL] [Abstract][Full Text] [Related]
60. [Identification of hepatitis B antigens in hepatic tissue in various forms of acute hepatitis]. Sarno EN; Vieira LM; Alvariz FG Arq Gastroenterol; 1984; 21(2):68-74. PubMed ID: 6393924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]